Jun 2026 (Q2 FY26) — Jul 30, 2026
Omega Healthcare Investors Q2 FY26 — Strategic Portfolio Management and Strong Investment Pipeline
Read the full callOmega Healthcare Investors (OHI) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Omega Healthcare Investors earnings: last reported Thu, 30 Jul 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 328 | +16.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 100.8 | +1.3 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 363 | +165.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$45.53 +0.98% · +$0.44
Performance +14.8% 1Y
1Y: $39.66 on 14 Oct 2025 → $45.53. High $51.72 (24 Jul 2026), low $39.53 (29 Oct 2025).
- Previous close
- $45.09
- 52-week range
- $39.53 – $51.72
- One year
- +13.60%
Overview
- Symbol
- OHI
- Sector
- Real Estate
- Exchange
- US
- Currency
- USD
Call summaries
Mar 2026 (Q1 FY26) — Apr 29, 2026
Omega Healthcare Investors Q1 FY26 — Strong AFFO/FAD Growth and Strategic Capital Allocation
Read the full callEvery analysed call
Omega Healthcare Investors earnings calls (OHI)
Financials
What the filings say
Net profit, year on year: +166% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 276 | 279 | 277 | 283 | 312 | 319 | 323 | 328 |
| Operating profit | — | — | — | 281 | — | — | — | 331 |
| Operating margin | — | — | — | 99.5% | — | — | — | 100.8% |
| Profit before tax | 111 | 119 | 115 | 147 | 191 | 171 | 160 | 380 |
| Tax rate | 3.0% | 2.5% | 3.1% | 3.1% | 2.3% | 1.2% | 3.2% | 1.2% |
| Net profit | 112 | 113 | 109 | 137 | 180 | 165 | 151 | 363 |
| EPS ($ per share) | 0.43 | — | 0.34 | 0.46 | 0.60 | — | 0.47 | 1.21 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 20 | 23 | 23 | 24 | 23 | 25 | 28 | 30 |
| Reserves | 2,131 | 2,463 | 2,595 | 3,011 | 3,438 | 3,681 | 4,087 | 4,677 |
| Total liabilities | 4,826 | 5,460 | 5,461 | 5,530 | 5,602 | 5,355 | 5,167 | 4,609 |
| Total assets | 8,591 | 9,796 | 9,497 | 9,638 | 9,405 | 9,117 | 9,898 | 10,049 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 499 | 554 | 708 | 722 | 626 | 618 | 749 | 879 |
| Cash from investing | -173 | -379 | -89 | -524 | 443 | -1 | -671 | -540 |
| Cash from financing | -411 | -154 | -486 | -341 | -789 | -473 | 26 | -838 |
| Net cash flow | -85 | 22 | 134 | -143 | 276 | 144 | 104 | -494 |
| Capital expenditure | -135 | -53 | -135 | -649 | -272 | -299 | -778 | -771 |
| Free cash flow | 364 | 501 | 573 | 73 | 353 | 319 | -29 | 107 |
OHI revenue by segment
| Segment | Q2 FY2026 | YoY growth latest quarter |
|---|---|---|
| Operating Portfolio | 100% | — |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
Insider filings
17 filings between Nov 5, 2025 and Oct 1, 2026.
Open market
decisions to buy or sellPurchases
$1.36M
2 purchases by 2 insiders
Sales
None
No insider sold shares.
Compensation
not trading decisions- 7
- Award — granted as compensation
- 1
- Tax withheld — shares kept back by the company to cover tax
Also filed: 4 gifts, 3 dispositions to the issuer.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| PICKETT C TAYLOR | $862.9K | — | Nov 5, 2025 |
| Gupta Vikas | $494.1K | — | Nov 6, 2025 |
Latest filings (39)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Golem Lucas M. CHIEF ACCOUNTING OFFICER | Award | 64 | $2.5K |
| Oct 1, 2026 | Golem Lucas M. CHIEF ACCOUNTING OFFICER | Disposition to issuer | 3 | $139 |
| Aug 7, 2026 | Egbuonu-Davis Lisa Director | Gift | 5,131 | $0 |
| Jul 1, 2026 | Ballew Neal CHIEF ACCOUNTING OFFICER | Award | 168 | $6.3K |
| Jul 1, 2026 | Ballew Neal CHIEF ACCOUNTING OFFICER | Disposition to issuer | 11 | $524 |
| Jun 5, 2026 | Egbuonu-Davis Lisa Director | Award | 3,778 | $165.0K |
| Jun 5, 2026 | WHITMAN BURKE W Director | Award | 3,778 | $165.0K |
| Jun 5, 2026 | Jacobs Kevin J Director | Award | 6,125 | $267.5K |
| Apr 1, 2026 | Ballew Neal CHIEF ACCOUNTING OFFICER | Disposition to issuer | 8 | $351 |
| Apr 1, 2026 | Ballew Neal CHIEF ACCOUNTING OFFICER | Award | 168 | $6.3K |
| Jan 1, 2026 | Ballew Neal CHIEF ACCOUNTING OFFICER | Tax withheld | 12 | $532 |
| Jan 1, 2026 | Ballew Neal CHIEF ACCOUNTING OFFICER | Award | 173 | $6.2K |
| Dec 31, 2025 | STEPHENSON ROBERT O CHIEF FINANCIAL OFFICER | Gift | 31,426 | $0 |
| Dec 31, 2025 | STEPHENSON ROBERT O CHIEF FINANCIAL OFFICER | Gift | 31,426 | $0 |
| Dec 30, 2025 | STEPHENSON ROBERT O CHIEF FINANCIAL OFFICER | Gift | 3,850 | $0 |
| Nov 6, 2025 | Gupta Vikas Chief Investment Officer | Purchase | 11,500 | $494.1K |
| Nov 5, 2025 | PICKETT C TAYLOR CHIEF EXECUTIVE OFFICER | Purchase | 20,000 | $862.9K |
| Oct 1, 2025 | Ballew Neal CHIEF ACCOUNTING OFFICER | Tax withheld | 17 | $718 |
| Oct 1, 2025 | Ballew Neal CHIEF ACCOUNTING OFFICER | Award | 201 | $6.3K |
| Aug 26, 2025 | STEPHENSON ROBERT O CHIEF FINANCIAL OFFICER | Gift | 800 | $0 |
| Aug 8, 2025 | Egbuonu-Davis Lisa Director | Sale | 2,300 | $92.4K |
| Aug 8, 2025 | Egbuonu-Davis Lisa Director | Sale | 200 | $8.0K |
| Jul 1, 2025 | Ballew Neal CHIEF ACCOUNTING OFFICER | Tax withheld | 9 | $330 |
| Jul 1, 2025 | Ballew Neal CHIEF ACCOUNTING OFFICER | Award | 200 | $6.2K |
| Jun 6, 2025 | WHITMAN BURKE W Director | Award | 4,388 | $165.0K |
| Jun 6, 2025 | Egbuonu-Davis Lisa Director | Award | 4,388 | $165.0K |
| Jun 6, 2025 | Jacobs Kevin J Director | Award | 7,114 | $267.5K |
| Apr 1, 2025 | Ballew Neal CHIEF ACCOUNTING OFFICER | Award | 195 | $6.3K |
| Apr 1, 2025 | Ballew Neal CHIEF ACCOUNTING OFFICER | Tax withheld | 9 | $343 |
| Jan 1, 2025 | Gourmand Matthew Paul President | Tax withheld | 9 | $341 |
| Jan 1, 2025 | Gourmand Matthew Paul President | Award | 174 | $5.6K |
| Jan 1, 2025 | Gupta Vikas Chief Investment Officer | Award | 192 | $6.2K |
| Jan 1, 2025 | Gupta Vikas Chief Investment Officer | Tax withheld | 10 | $379 |
| Jan 1, 2025 | Ballew Neal CHIEF ACCOUNTING OFFICER | Tax withheld | 10 | $379 |
| Jan 1, 2025 | Ballew Neal CHIEF ACCOUNTING OFFICER | Award | 193 | $6.2K |
| Oct 1, 2024 | Ballew Neal CHIEF ACCOUNTING OFFICER | Award | 215 | $6.3K |
| Sep 27, 2024 | STEPHENSON ROBERT O CHIEF FINANCIAL OFFICER | Sale | 22,542 | $906.0K |
| Sep 27, 2024 | BOOTH DANIEL J CHIEF OPERATING OFFICER | Sale | 56,725 | $2.28M |
| Sep 5, 2024 | BOOTH DANIEL J CHIEF OPERATING OFFICER | Sale | 25,000 | $1.00M |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for OMEGA HEALTHCARE INVESTORS INC
Free account. Everything above stays public.
Write why you follow OMEGA HEALTHCARE INVESTORS INC and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading